Maximus, Inc.
—- Market cap
- $2.96B
- Debt
- —
- Cash
- −$222.35M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: MMS stock price at discount vs CSGP $56.53 current versus $8.12K implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CSGP's multiple
Implied fair value · at MMS's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Maximus, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
COSTAR GROUP, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Accenture plc
MMS vs ACN
INTERNATIONAL BUSINESS MACHINES CORP
MMS vs IBM
CACI INTERNATIONAL INC /DE/
MMS vs CACI
ROLLINS INC
MMS vs ROL
CINTAS CORP
MMS vs CTAS
IRON MOUNTAIN INC
MMS vs IRM
WELLTOWER INC.
MMS vs WELL
Prologis, Inc.
MMS vs PLD
Public Storage
MMS vs PSA
EQUITY RESIDENTIAL
MMS vs EQR
CROWN CASTLE INC.
MMS vs CCI
CENTERSPACE
MMS vs CSR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CSGP's growth will not quickly translate into sustained earnings power, then prefer MMS because it is materially cheaper on earnings and sales multiples while already producing stronger margins and returns.
The valuation gap is extreme: the P/E-based implied price for MMS is $7,923.38 versus the current price of $60.25, reflecting a 13,050.8% upside that is clearly driven by CSGP's 1,438.0x P/E multiple. On simpler operating multiples, MMS also looks cheaper at 0.6x P/S and 6.4x EV/EBITDA versus CSGP at 3.6x P/S and 41.3x EV/EBITDA.
Supporting Metrics